Evidence map›Paper›PMID 32328185›Full record

ArticleJournal of Cancer2020

Integrin αvβ8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-β1.

Mingliang Zhou, Jun Niu, Jinshen Wang, Huijie Gao, Muhammad Shahbaz, Zhengchuan Niu, Zequn Li, Xueqing Zou, Benjia Liang

Abstract read
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  9. Article
  10. CSK-mediated signalling by integrins in cancer.Frontiers in cell and developmental biology · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. TGFβ: Signaling Blockade for Cancer Immunotherapy.Annual review of cancer biology · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mingliang ZhouDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.
Jun NiuDepartment of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan 250012 Shandong, China.
Jinshen WangDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.
Huijie GaoDepartment of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan 250012 Shandong, China.
Muhammad ShahbazDepartment of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan 250012 Shandong, China.
Zhengchuan NiuDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 20032, China.
Zequn LiDepartment of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China.
Xueqing ZouDepartment of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China.
Benjia LiangDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrin αvβ8 expressed on tumor cells executes crucial regulatory functions during cell adhesion in the tumor microenvironment and supports the activation of TGF-β1. This study aimed to investigate the expression of integrin αvβ8 and its clinical significance in colon cancer, in addition to its influence on the invasion and migration of cancer cells. Our results showed that integrin αvβ8 was an indicator of progression and poor prognosis in patients with colon cancer. Moreover, integrin αvβ8 significantly promoted the invasion and migration of colon cancer cells by the activation of TGF-β1 and upregulation of metalloproteinase-9. Furthermore, suppression of integrin αvβ8 was found to inhibit the growth of colon cancer

Indexed as

cell invasivenesscolon cancerintegrin αvβ8prognostic factorsTGF-β1

Identifiers

PMID32328185
PMCPMC7171496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.